| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 20 | 2025 | 469 | 4.990 |
Why?
|
| Diet | 18 | 2025 | 1194 | 3.420 |
Why?
|
| Autistic Disorder | 6 | 2023 | 376 | 3.090 |
Why?
|
| Autism Spectrum Disorder | 8 | 2023 | 429 | 2.840 |
Why?
|
| Leiomyoma | 4 | 2022 | 85 | 2.230 |
Why?
|
| Feeding Behavior | 9 | 2025 | 731 | 2.220 |
Why?
|
| Endometriosis | 10 | 2025 | 186 | 2.170 |
Why?
|
| Breast Neoplasms | 13 | 2025 | 2771 | 2.130 |
Why?
|
| Postmenopause | 9 | 2025 | 155 | 2.090 |
Why?
|
| Parenting | 5 | 2024 | 348 | 1.830 |
Why?
|
| Women's Health | 9 | 2025 | 150 | 1.660 |
Why?
|
| Premenopause | 2 | 2025 | 42 | 1.650 |
Why?
|
| Uterine Neoplasms | 4 | 2022 | 112 | 1.600 |
Why?
|
| Pesticide Residues | 2 | 2022 | 5 | 1.580 |
Why?
|
| Pesticides | 2 | 2022 | 31 | 1.540 |
Why?
|
| Risk Factors | 45 | 2025 | 11184 | 1.390 |
Why?
|
| Proportional Hazards Models | 16 | 2025 | 1486 | 1.330 |
Why?
|
| Infertility | 4 | 2025 | 82 | 1.280 |
Why?
|
| Sweden | 19 | 2021 | 57 | 1.260 |
Why?
|
| Infertility, Female | 3 | 2025 | 151 | 1.260 |
Why?
|
| Female | 84 | 2025 | 72004 | 1.180 |
Why?
|
| Talc | 3 | 2021 | 4 | 1.070 |
Why?
|
| Middle Aged | 53 | 2025 | 29395 | 1.030 |
Why?
|
| Endometrial Neoplasms | 2 | 2024 | 116 | 1.020 |
Why?
|
| Feeding and Eating Disorders | 2 | 2024 | 76 | 1.010 |
Why?
|
| Humans | 100 | 2025 | 134145 | 1.000 |
Why?
|
| Prospective Studies | 27 | 2025 | 6610 | 0.990 |
Why?
|
| Menarche | 1 | 2025 | 37 | 0.940 |
Why?
|
| Pediatric Obesity | 2 | 2020 | 413 | 0.920 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2025 | 104 | 0.900 |
Why?
|
| Parity | 4 | 2025 | 89 | 0.880 |
Why?
|
| Case-Control Studies | 21 | 2025 | 3677 | 0.870 |
Why?
|
| Appetite | 1 | 2023 | 35 | 0.840 |
Why?
|
| Aged | 40 | 2025 | 21789 | 0.840 |
Why?
|
| Meals | 2 | 2022 | 61 | 0.820 |
Why?
|
| Menstrual Cycle | 3 | 2022 | 37 | 0.740 |
Why?
|
| Overweight | 3 | 2025 | 387 | 0.740 |
Why?
|
| Breast Density | 1 | 2021 | 2 | 0.730 |
Why?
|
| Surveys and Questionnaires | 18 | 2024 | 4006 | 0.730 |
Why?
|
| Feminine Hygiene Products | 1 | 2021 | 1 | 0.730 |
Why?
|
| Body Mass Index | 7 | 2025 | 1722 | 0.720 |
Why?
|
| Hyperphagia | 2 | 2024 | 46 | 0.710 |
Why?
|
| Dacryocystitis | 1 | 2020 | 21 | 0.690 |
Why?
|
| Gastrointestinal Diseases | 2 | 2023 | 362 | 0.680 |
Why?
|
| Food Assistance | 1 | 2020 | 37 | 0.670 |
Why?
|
| Eye Infections, Bacterial | 1 | 2020 | 87 | 0.660 |
Why?
|
| Anthropometry | 1 | 2020 | 205 | 0.650 |
Why?
|
| Father-Child Relations | 1 | 2020 | 22 | 0.650 |
Why?
|
| Adult | 32 | 2025 | 31944 | 0.630 |
Why?
|
| Adenomyosis | 3 | 2025 | 14 | 0.630 |
Why?
|
| Erythrocytes | 1 | 2020 | 234 | 0.630 |
Why?
|
| Fathers | 1 | 2020 | 73 | 0.620 |
Why?
|
| Smoking | 6 | 2025 | 1135 | 0.610 |
Why?
|
| DNA Methylation | 3 | 2025 | 1148 | 0.610 |
Why?
|
| Incidence | 14 | 2025 | 3421 | 0.600 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 771 | 0.590 |
Why?
|
| Dietary Fats | 1 | 2020 | 300 | 0.590 |
Why?
|
| Child, Preschool | 15 | 2025 | 14895 | 0.580 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 238 | 0.570 |
Why?
|
| Child Development | 1 | 2020 | 286 | 0.570 |
Why?
|
| Mammography | 5 | 2021 | 133 | 0.570 |
Why?
|
| Alcohol Drinking | 3 | 2020 | 387 | 0.570 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 652 | 0.560 |
Why?
|
| Fatty Acids | 1 | 2020 | 372 | 0.560 |
Why?
|
| Parents | 5 | 2024 | 1072 | 0.540 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2025 | 243 | 0.530 |
Why?
|
| Follow-Up Studies | 13 | 2025 | 5465 | 0.530 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2017 | 212 | 0.520 |
Why?
|
| Fruit | 4 | 2022 | 238 | 0.510 |
Why?
|
| Netherlands | 4 | 2024 | 47 | 0.500 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 46 | 0.500 |
Why?
|
| Inflammation | 6 | 2025 | 1595 | 0.490 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2022 | 228 | 0.490 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2016 | 76 | 0.480 |
Why?
|
| Life Style | 2 | 2020 | 463 | 0.480 |
Why?
|
| United States | 14 | 2025 | 11777 | 0.460 |
Why?
|
| Tea | 2 | 2022 | 19 | 0.440 |
Why?
|
| Primary Health Care | 1 | 2020 | 805 | 0.440 |
Why?
|
| Obesity | 5 | 2025 | 2448 | 0.420 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 3 | 2025 | 312 | 0.420 |
Why?
|
| Genetic Testing | 1 | 2020 | 1105 | 0.420 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1091 | 0.420 |
Why?
|
| Paternal Behavior | 1 | 2013 | 12 | 0.410 |
Why?
|
| Child | 15 | 2025 | 25911 | 0.410 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 82 | 0.400 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 795 | 0.400 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2016 | 214 | 0.400 |
Why?
|
| Vegetables | 4 | 2022 | 276 | 0.400 |
Why?
|
| Maternal Behavior | 1 | 2013 | 71 | 0.390 |
Why?
|
| Selenium | 1 | 2012 | 20 | 0.390 |
Why?
|
| Coffee | 1 | 2012 | 30 | 0.380 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 475 | 0.380 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2013 | 94 | 0.380 |
Why?
|
| Child Behavior | 3 | 2024 | 235 | 0.380 |
Why?
|
| Breast Feeding | 2 | 2025 | 245 | 0.380 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2019 | 638 | 0.370 |
Why?
|
| Beverages | 1 | 2012 | 102 | 0.370 |
Why?
|
| Vitamin B Complex | 1 | 2011 | 44 | 0.360 |
Why?
|
| Aortic Aneurysm, Abdominal | 3 | 2022 | 450 | 0.360 |
Why?
|
| Rett Syndrome | 2 | 2025 | 294 | 0.350 |
Why?
|
| Folic Acid | 2 | 2023 | 297 | 0.350 |
Why?
|
| Powders | 2 | 2021 | 28 | 0.350 |
Why?
|
| Dietary Supplements | 2 | 2020 | 489 | 0.350 |
Why?
|
| Odds Ratio | 7 | 2025 | 1338 | 0.340 |
Why?
|
| C-Reactive Protein | 6 | 2025 | 471 | 0.340 |
Why?
|
| Exercise | 5 | 2025 | 872 | 0.330 |
Why?
|
| Adolescent | 10 | 2025 | 20643 | 0.330 |
Why?
|
| Cohort Studies | 10 | 2025 | 5219 | 0.330 |
Why?
|
| Male | 23 | 2025 | 66171 | 0.320 |
Why?
|
| Logistic Models | 6 | 2025 | 1908 | 0.320 |
Why?
|
| Pregnancy | 7 | 2025 | 7600 | 0.270 |
Why?
|
| Infant | 6 | 2022 | 13256 | 0.260 |
Why?
|
| Risk Assessment | 7 | 2025 | 3752 | 0.260 |
Why?
|
| Body Weight | 2 | 2020 | 1041 | 0.250 |
Why?
|
| Neoplasms | 4 | 2025 | 3035 | 0.240 |
Why?
|
| Soy Foods | 1 | 2025 | 10 | 0.240 |
Why?
|
| Androgens | 2 | 2019 | 300 | 0.240 |
Why?
|
| Parent-Child Relations | 2 | 2024 | 254 | 0.240 |
Why?
|
| Cognition | 2 | 2021 | 819 | 0.230 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2024 | 20 | 0.230 |
Why?
|
| Waist Circumference | 1 | 2025 | 95 | 0.230 |
Why?
|
| Isoflavones | 1 | 2025 | 46 | 0.230 |
Why?
|
| Adipokines | 1 | 2025 | 73 | 0.230 |
Why?
|
| DNA Repair Enzymes | 1 | 2025 | 48 | 0.230 |
Why?
|
| DNA Modification Methylases | 1 | 2025 | 52 | 0.230 |
Why?
|
| Diet Surveys | 3 | 2020 | 103 | 0.230 |
Why?
|
| Cigarette Smoking | 2 | 2023 | 80 | 0.230 |
Why?
|
| Catatonia | 1 | 2024 | 15 | 0.230 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2024 | 51 | 0.220 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2025 | 146 | 0.220 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 3758 | 0.210 |
Why?
|
| Appetitive Behavior | 1 | 2023 | 15 | 0.210 |
Why?
|
| Mouth Neoplasms | 1 | 2025 | 116 | 0.210 |
Why?
|
| Genome-Wide Association Study | 3 | 2023 | 1880 | 0.210 |
Why?
|
| Retrospective Studies | 5 | 2022 | 17565 | 0.210 |
Why?
|
| Nurses | 2 | 2021 | 75 | 0.210 |
Why?
|
| Satiation | 1 | 2023 | 25 | 0.210 |
Why?
|
| Constipation | 2 | 2022 | 128 | 0.210 |
Why?
|
| Appetite Regulation | 1 | 2023 | 43 | 0.210 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 7232 | 0.200 |
Why?
|
| Siblings | 1 | 2024 | 202 | 0.200 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 106 | 0.200 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2025 | 151 | 0.200 |
Why?
|
| Receptors, Estrogen | 2 | 2020 | 830 | 0.200 |
Why?
|
| Laparoscopy | 2 | 2025 | 520 | 0.200 |
Why?
|
| Aortic Rupture | 2 | 2021 | 124 | 0.200 |
Why?
|
| Marijuana Smoking | 1 | 2023 | 33 | 0.200 |
Why?
|
| Gene Duplication | 2 | 2024 | 372 | 0.200 |
Why?
|
| Phenotype | 2 | 2024 | 4605 | 0.200 |
Why?
|
| Fetal Blood | 1 | 2023 | 178 | 0.200 |
Why?
|
| Cholesterol | 1 | 2025 | 574 | 0.190 |
Why?
|
| Activities of Daily Living | 1 | 2025 | 432 | 0.190 |
Why?
|
| Age Factors | 3 | 2025 | 2997 | 0.190 |
Why?
|
| CpG Islands | 1 | 2023 | 347 | 0.190 |
Why?
|
| Cannabis | 1 | 2023 | 52 | 0.190 |
Why?
|
| Colonic Neoplasms | 1 | 2025 | 271 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2025 | 510 | 0.190 |
Why?
|
| Fragile X Syndrome | 1 | 2022 | 155 | 0.180 |
Why?
|
| Eating | 1 | 2024 | 395 | 0.180 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 482 | 0.180 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 20 | 0.180 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2021 | 10 | 0.180 |
Why?
|
| Aspirin | 1 | 2023 | 231 | 0.180 |
Why?
|
| Smokers | 1 | 2021 | 45 | 0.180 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2021 | 6 | 0.180 |
Why?
|
| Nutritionists | 1 | 2020 | 10 | 0.170 |
Why?
|
| Glioblastoma | 1 | 2025 | 372 | 0.170 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 2020 | 4 | 0.170 |
Why?
|
| Pennsylvania | 1 | 2020 | 60 | 0.170 |
Why?
|
| Self Report | 1 | 2024 | 553 | 0.170 |
Why?
|
| Sex Characteristics | 1 | 2022 | 337 | 0.170 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2020 | 17 | 0.170 |
Why?
|
| Trans Fatty Acids | 1 | 2020 | 11 | 0.170 |
Why?
|
| Sleep Wake Disorders | 1 | 2023 | 188 | 0.170 |
Why?
|
| Dairy Products | 1 | 2020 | 47 | 0.170 |
Why?
|
| Schools | 1 | 2022 | 238 | 0.170 |
Why?
|
| Language Development | 1 | 2020 | 36 | 0.170 |
Why?
|
| Grounded Theory | 1 | 2020 | 13 | 0.170 |
Why?
|
| Motor Skills | 1 | 2020 | 85 | 0.170 |
Why?
|
| Child Health Services | 1 | 2020 | 88 | 0.160 |
Why?
|
| Mutation, Missense | 1 | 2024 | 948 | 0.160 |
Why?
|
| Breast | 1 | 2021 | 218 | 0.160 |
Why?
|
| Microarray Analysis | 1 | 2020 | 239 | 0.160 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 126 | 0.160 |
Why?
|
| Nutritional Status | 1 | 2022 | 325 | 0.160 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1492 | 0.160 |
Why?
|
| Young Adult | 6 | 2025 | 9960 | 0.160 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2020 | 76 | 0.160 |
Why?
|
| Body Height | 1 | 2020 | 230 | 0.160 |
Why?
|
| Genitalia, Female | 1 | 2020 | 50 | 0.160 |
Why?
|
| Hypercholesterolemia | 1 | 2022 | 236 | 0.160 |
Why?
|
| Mutation | 4 | 2025 | 6341 | 0.160 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 1721 | 0.160 |
Why?
|
| Androsterone | 1 | 2019 | 4 | 0.160 |
Why?
|
| Inpatients | 1 | 2023 | 549 | 0.150 |
Why?
|
| Carcinosarcoma | 1 | 2019 | 12 | 0.150 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 103 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2019 | 83 | 0.150 |
Why?
|
| Focus Groups | 1 | 2020 | 212 | 0.150 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2019 | 25 | 0.150 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2019 | 40 | 0.150 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 41 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2013 | 1595 | 0.150 |
Why?
|
| Mosaicism | 1 | 2020 | 248 | 0.150 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2019 | 58 | 0.150 |
Why?
|
| Hysterectomy | 1 | 2020 | 201 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2024 | 1167 | 0.150 |
Why?
|
| Meat Products | 1 | 2018 | 6 | 0.150 |
Why?
|
| Red Meat | 1 | 2018 | 8 | 0.140 |
Why?
|
| Streptococcus pneumoniae | 1 | 2020 | 380 | 0.140 |
Why?
|
| World Health Organization | 1 | 2018 | 119 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 141 | 0.140 |
Why?
|
| Longitudinal Studies | 4 | 2025 | 1510 | 0.140 |
Why?
|
| Weight Gain | 1 | 2020 | 414 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 681 | 0.140 |
Why?
|
| Emotions | 1 | 2020 | 365 | 0.140 |
Why?
|
| Gene Deletion | 1 | 2020 | 811 | 0.140 |
Why?
|
| Poverty | 1 | 2020 | 438 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 482 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2023 | 547 | 0.130 |
Why?
|
| Mothers | 1 | 2020 | 372 | 0.130 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 480 | 0.130 |
Why?
|
| New England | 1 | 2016 | 13 | 0.130 |
Why?
|
| Mortality | 1 | 2018 | 261 | 0.130 |
Why?
|
| Dinoprost | 1 | 2016 | 30 | 0.130 |
Why?
|
| F2-Isoprostanes | 1 | 2016 | 21 | 0.130 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 15 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 316 | 0.130 |
Why?
|
| Communication | 1 | 2021 | 542 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2020 | 574 | 0.130 |
Why?
|
| Weight Loss | 1 | 2020 | 518 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 258 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2025 | 3508 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 317 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2020 | 648 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 1771 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 320 | 0.120 |
Why?
|
| Carcinoma | 1 | 2018 | 321 | 0.120 |
Why?
|
| Cathepsins | 1 | 2015 | 26 | 0.120 |
Why?
|
| Estrone | 1 | 2015 | 13 | 0.120 |
Why?
|
| Ovary | 1 | 2018 | 390 | 0.120 |
Why?
|
| Pandemics | 1 | 2022 | 1193 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 676 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 84 | 0.110 |
Why?
|
| Risk | 1 | 2016 | 833 | 0.110 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2014 | 111 | 0.110 |
Why?
|
| Macrophages | 1 | 2018 | 710 | 0.110 |
Why?
|
| Hypertension | 1 | 2022 | 1407 | 0.100 |
Why?
|
| Australia | 2 | 2024 | 186 | 0.100 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 317 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 1391 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1164 | 0.100 |
Why?
|
| Estradiol | 1 | 2015 | 559 | 0.100 |
Why?
|
| Food Preferences | 1 | 2013 | 118 | 0.100 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2025 | 16 | 0.100 |
Why?
|
| Ovulation Induction | 1 | 2012 | 42 | 0.090 |
Why?
|
| Caffeine | 1 | 2012 | 70 | 0.090 |
Why?
|
| Survival Rate | 2 | 2019 | 2212 | 0.090 |
Why?
|
| Genomic Imprinting | 1 | 2012 | 130 | 0.090 |
Why?
|
| Birth Weight | 1 | 2013 | 356 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2016 | 1258 | 0.090 |
Why?
|
| Fertilization in Vitro | 1 | 2012 | 163 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2734 | 0.090 |
Why?
|
| Antioxidants | 1 | 2013 | 373 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1419 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1922 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2025 | 450 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1255 | 0.080 |
Why?
|
| Biomarkers | 4 | 2025 | 3431 | 0.080 |
Why?
|
| Alleles | 3 | 2024 | 1724 | 0.080 |
Why?
|
| Neoplasm Grading | 2 | 2021 | 308 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2587 | 0.070 |
Why?
|
| Registries | 3 | 2021 | 1586 | 0.070 |
Why?
|
| Prognosis | 4 | 2021 | 5084 | 0.070 |
Why?
|
| Washington | 1 | 2025 | 35 | 0.060 |
Why?
|
| Adiponectin | 1 | 2025 | 129 | 0.060 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2024 | 17 | 0.060 |
Why?
|
| Cause of Death | 2 | 2018 | 506 | 0.060 |
Why?
|
| Sterilization, Tubal | 1 | 2024 | 17 | 0.060 |
Why?
|
| Contraceptives, Oral | 1 | 2024 | 41 | 0.060 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 143 | 0.050 |
Why?
|
| England | 1 | 2024 | 72 | 0.050 |
Why?
|
| Sensation Disorders | 1 | 2024 | 25 | 0.050 |
Why?
|
| Leptin | 1 | 2025 | 224 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2025 | 395 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3867 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2024 | 229 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2091 | 0.050 |
Why?
|
| Tobacco Products | 1 | 2023 | 72 | 0.050 |
Why?
|
| Social Support | 1 | 2024 | 389 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 608 | 0.050 |
Why?
|
| Protective Factors | 1 | 2021 | 91 | 0.040 |
Why?
|
| Progestins | 1 | 2021 | 53 | 0.040 |
Why?
|
| Cultured Milk Products | 1 | 2020 | 1 | 0.040 |
Why?
|
| Social Behavior | 1 | 2022 | 230 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2025 | 1434 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2021 | 118 | 0.040 |
Why?
|
| Time | 1 | 2020 | 101 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 699 | 0.040 |
Why?
|
| Psychometrics | 1 | 2024 | 690 | 0.040 |
Why?
|
| Time Factors | 2 | 2021 | 6592 | 0.040 |
Why?
|
| Rural Population | 1 | 2022 | 281 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 15 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2025 | 897 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2020 | 96 | 0.040 |
Why?
|
| Sleep | 1 | 2023 | 370 | 0.040 |
Why?
|
| Beer | 1 | 2019 | 5 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2024 | 742 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2019 | 99 | 0.040 |
Why?
|
| Wine | 1 | 2019 | 15 | 0.040 |
Why?
|
| Feedback | 1 | 2020 | 173 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2019 | 104 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2019 | 42 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2019 | 97 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 1036 | 0.040 |
Why?
|
| Glucuronides | 1 | 2019 | 29 | 0.040 |
Why?
|
| Teaching | 1 | 2020 | 200 | 0.040 |
Why?
|
| Menorrhagia | 1 | 2019 | 82 | 0.040 |
Why?
|
| Telomerase | 1 | 2019 | 179 | 0.040 |
Why?
|
| Uterus | 1 | 2022 | 587 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 150 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2021 | 480 | 0.040 |
Why?
|
| Educational Status | 1 | 2019 | 298 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 245 | 0.030 |
Why?
|
| SEER Program | 1 | 2019 | 224 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2020 | 363 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 3056 | 0.030 |
Why?
|
| Food | 1 | 2017 | 140 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 294 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1764 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2019 | 4936 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2014 | 78 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2015 | 138 | 0.030 |
Why?
|
| Epilepsy | 1 | 2022 | 898 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2683 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 756 | 0.030 |
Why?
|
| Adiposity | 1 | 2014 | 207 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1627 | 0.030 |
Why?
|
| Energy Intake | 1 | 2015 | 518 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 920 | 0.020 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2012 | 76 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1344 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2949 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1761 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 8636 | 0.010 |
Why?
|